LXA4 has been shown to restore oxidative stress-induced vascular endothelial cell injury by activating the Nrf2-HO-1 axis, thereby offering a promising strategy for managing venous thromboembolism and its complications [42]. This evidence concerns the gene HMOX1 and venous thromboembolism.